CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma

Status Not yet recruiting

Clinical Trial Summary

Contrast-enhanced ultrasound (CEUS) can sensitively show the blood perfusion characteristics of thyroid nodules, which is a useful supplement to gray-scale ultrasound. However, there is no standard combined diagnostic method of gray-scale ultrasound and CEUS. Therefore, the aim of this study was to compare the diagnostic performance of the integrated scoring method and the up-and-down scoring method. This study was a multicenter retrospective clinical study and followed the Standards for Reporting of Diagnostic Accuracy Studies (version 2015). Inclusion criteria: 1) participants with at least one thyroid nodule larger than 5 mm confirmed by conventional ultrasound; 2) participants underwent gray-scale ultrasound, contrast-enhanced ultrasound and fine needle aspiration biopsy of the thyroid nodule successively; 3) participants have a final diagnosis of benign or malignant. Exclusion criteria included: 1) participants with cytologic findings of Bethesda I, III, or IV without definitive benign or malignant pathologic findings; 2) participants with a history of thyroid fine needle aspiration, ablation or surgery; 3) participants with low quality ultrasound images (e.g., severe artifacts or low image resolution). According to the American College of Radiology Thyroid Imaging Reporting and Data System, only one thyroid nodule with the highest point was included in each participant. A total of 600 participants from January 2018 to December 2022 were consecutively included in Sun Yat-sen Memorial Hospital of Sun Yat-sen University to form a training set (average age 48 years; Range 24-81 years old). A total of 200 subjects with thyroid nodules from January 2022 to December 2022 were consecutively included to form an external validation set in Houjie Hospital of Dongguan City, Guangdong Province (mean age 46 years; Range 30-74 years). The malignant risk of enrolled thyroid nodules and the necessity of biopsy were evaluated by integrated scoring method and up-and-down scoring method, respectively. The diagnostic performance and unnecessary biopsy rate of the above two methods were calculated and compared.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06146764
Study type	Observational
Source	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Contact	Jingliang Ruan, PhD
Phone	+8613694202230
Email	ruanjl3@mail.sysu.edu.cn
Status	Not yet recruiting
Phase
Start date	January 1, 2024
Completion date	April 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04614389` - Utility of Contrast-Enhanced Sonography and Shear Wave Elastography	N/A
Recruiting	`NCT03295955` - Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy	N/A
Completed	`NCT04647006` - Comparison of TOETVA and Conventional Thyroidectomy	N/A
Not yet recruiting	`NCT06029946` - B-mode Ultrasound, Sono-Elastography, and Diffusion-weighted Imaging MRI in Thyroid Nodules
Recruiting	`NCT05025046` - NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
Terminated	`NCT01320813` - Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy	N/A
Completed	`NCT00877630` - Minimal Invasiveness of Endoscopic Thyroidectomy	N/A
Completed	`NCT01964508` - microRNA in Thyroid Cancer
Completed	`NCT06306599` - Ultrasound Operator Influence on Diagnostics With AI for Thyroid Nodules - Clinial Trial	N/A
Recruiting	`NCT04730726` - In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules	N/A
Not yet recruiting	`NCT03884140` - Clinical Diagnostic Approach for Cases of Thyroid Nodules
Recruiting	`NCT02225509` - Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology	N/A
Completed	`NCT00552253` - Levothyroxine Treatment in Thyroid Benign Nodular Goiter	N/A
Not yet recruiting	`NCT03700762` - Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.
Enrolling by invitation	`NCT01757834` - Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules	N/A
Completed	`NCT01292044` - The Role of Elastography in the Diagnosis of Thyroid Nodules	N/A
Completed	`NCT00858104` - Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results	Phase 4
Completed	`NCT00651625` - Reciprocating Medical Devices - a Study of a New Safety Device	N/A
Completed	`NCT05132478` - The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer	N/A
Withdrawn	`NCT03395925` - Evaluation of the Thyroid Volume After Radiofrequency Ablation of Thyroid Nodules and Recurrent Thyroid	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.